Expressions of cyclinBl, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance

National Medical Journal of China

Volumn 89, Issue 33, 2009, Pages 2337-2341

  Li, Ya Zhuo ^a   Zhao, Po ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Carcinoma; Immunohistochemistry; Stomach neoplasms

Indexed keywords

ACID ANHYDRIDE HYDROLASE; CYCLIN B1; FRAGILE HISTIDINE TRIAD PROTEIN; KI 67 ANTIGEN; TUMOR PROTEIN;

ARTICLE; CANCER STAGING; CARCINOMA; HUMAN; METABOLISM; PATHOLOGY; STOMACH TUMOR; SURVIVAL RATE;

ACID ANHYDRIDE HYDROLASES; CARCINOMA; CYCLIN B1; HUMANS; KI-67 ANTIGEN; NEOPLASM PROTEINS; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84871904944     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.33.009     Document Type: Article

References (16)

1. Sard LA, Aecomero P, Tomielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci Am, 1999, 96: 8489.
2. Kawaguchi K, Yashima K, Koda M, et al. Thit expression in human gastric adenomas and intramucosal carcinomas; correlation with Mlhl expression and gastric phenotype. Br J Cancer, 2004, 90: 672.
3. 2006, 86: 2171-2176.
4. Collecchi P, Santoni T, Gnesi E, et al. Cyclins of phases Gl, S and G2/M are overexpressed in aneuploid mammary carcinomas. Cytometry, 2000, 42: 254-260.
5. Megha T, Lazzi S, Ferrari F, et al. Expression of the G2/M checkpoint regulators CyclinBl and p34 in breast cancer; a correlation with cellular kinetics. Anticancer Res, 1999, 19: 163-169.
6. Katherine LB, Barrett D, Demiranda D, et al. CyclinBl promoter activity and functional in Gl phase of human breast cancer cells. Cell Lnt, 2002, 26: 19-28.
7. Yuan J, Yan R, Krimer AL, et al. CyclinBl depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene, 2004, 23: 5843-5852.
8. Kim. Prognostic implications of cyclinBl, p34cdc2 , p27 ( Kipl) and p53 expression in gastric cancer. Yonsei Med J, 2007 , 48: 694-700.
9. Brien TP, Depowski PL, Sheehan CE, et al. Prognostic factors in gastric cancer. Mod Pathol, 1998, 11: 870-877.
10. Czyzewska J, Ustymowicz K, Lebelt A, et al. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers. Rocz Akad Med Bialymst, 2004, 49Suppl: 64-66.
11. Oshima C, Iriya A, Forones NM. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer. Neoplasma, 2005 , 52: 420-424.
12. Guo Z, Johansson SL, Rhim JS, et al. Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model. Prostate, 2000, 43 : 101-110.
13. 2002, 82: 1375-1377.
14. Bragantini E, Barbi S, Beghelli S, et al. Loss of Thit expression is associated with poorer Survival in gastric cancer but is not an independent prognosis marker. J Cancer Res Clin Oncol, 2006,132: 45.
15. 2004, 12: 516-519.
16. Guo Z, Vishwanatha JK. Effect of regulated expression of the fragile histidine triad gene on cell cycle and proliferation. Mol Cell Biochem, 2000, 204:83.